A Phase Ib Study of VK-2019 in Patients With Relapsed or Refractory EBV+ Diffuse Large B-cell Lymphomas (DLBCL)

Clinical trial NCT06789159 · RECRUITING

Trial details

NCT number: NCT06789159
Sponsor: Pierluigi Porcu
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma Refractory Diffuse Large B Cell Lymphoma Relapsed Epstein-Barr Virus (EBV) Infection

Start date: 2026-08-01
Primary completion: 2028-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.